GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Huakang Century Medical Co Ltd (SZSE:301235) » Definitions » 3-Year EBITDA Growth Rate

Wuhan Huakang Century Medical Co (SZSE:301235) 3-Year EBITDA Growth Rate : 18.70% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Wuhan Huakang Century Medical Co 3-Year EBITDA Growth Rate?

Wuhan Huakang Century Medical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥-0.27.

During the past 12 months, Wuhan Huakang Century Medical Co's average EBITDA Per Share Growth Rate was 6.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Wuhan Huakang Century Medical Co was 18.70% per year. The lowest was 10.30% per year. And the median was 14.50% per year.


Competitive Comparison of Wuhan Huakang Century Medical Co's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Wuhan Huakang Century Medical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Huakang Century Medical Co's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Huakang Century Medical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Wuhan Huakang Century Medical Co's 3-Year EBITDA Growth Rate falls into.



Wuhan Huakang Century Medical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Wuhan Huakang Century Medical Co  (SZSE:301235) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Wuhan Huakang Century Medical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Wuhan Huakang Century Medical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Huakang Century Medical Co (SZSE:301235) Business Description

Traded in Other Exchanges
N/A
Address
No. 77 Optics Valley Avenue, Floor 8-9, Building B4, Optics Valley Financial Port, Wuhan East Lake New Technology Development Zone, Hubei Province, Wuhan, CHN, 430000
Wuhan Huakang Century Medical Co Ltd is engaged in the research and development, design, implementation and operation and maintenance of medical purification systems, sales of related medical equipment and medical consumables.

Wuhan Huakang Century Medical Co (SZSE:301235) Headlines

No Headlines